JIE MENG | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. JIE MENG | Neuroscience | Best Researcher Award 🏆

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education 🎓:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience 💼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimer’s disease and Parkinson’s disease.

Awards and Honors

Jie Meng’s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Meng’s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinson’s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinson’s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

📚 Publication 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

Conclusion 

In conclusion, to fully assess Dr. Jie Meng’s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher Award 🏆

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education 🎓:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience 💼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumar’s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harender’s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

📚 Publications 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

Conclusion 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Hristina Čolović | Neuroscience | Robotics Integration Award

Posted on by sciencefather

Prof. Dr. Hristina Čolović | Neuroscience | Robotics Integration Award

spec.Physical Medicine and Rehabilitation at University of Nis, Faculty of Medicine, Serbia 2 Physical Medicine and Rehabilitation Clinic, Clinical Center of Nis, Serbia, Serbia🎓

Dr. Hristina Čolović is an accomplished Physiatrist specializing in physical medicine and rehabilitation, with a particular focus on pediatric rehabilitation and the use of botulinum toxin in treating spasticity in children with cerebral palsy. With a robust academic background, including a PhD in Physical Medicine and Rehabilitation, she has made significant contributions to the field, especially in robotic neurorehabilitation after pediatric stroke. She is actively involved in clinical practice, research, and teaching, and has a record of publications in notable scientific journals.

 

Profile 

Scopus

Education 🎓:

Dr. Hristina Čolović completed her undergraduate studies at the Faculty of Medicine, University of Nis, Serbia, in 1992, with a distinguished average grade of 9.06. She pursued specialization in Physical Medicine and Rehabilitation at the same institution, receiving excellent grades (5/5) in 1998. Dr. Čolović furthered her expertise with a subspecialization in Pediatric Rehabilitation from the Faculty of Medicine, University of Belgrade, in 2007, earning another top grade. She completed her Ph.D. in 2012, focusing on the effects of Botulinum toxin type A in the habilitation of children with cerebral palsy. Her academic foundation and continuing education have provided a solid basis for her leadership in both clinical practice and research. Dr. Čolović’s ongoing commitment to academic development is reflected in her teaching roles, where she lectures on physical medicine, pediatric rehabilitation, and neurorehabilitation at the University of Nis and other institutions.

Work Experience 💼:

Dr. Hristina Čolović has an extensive career in physical medicine and rehabilitation, spanning over 25 years. She has been a full-time faculty member at the Clinic for Physical Medicine, Rehabilitation, and Prosthetics in Nis, Serbia, since 1995. Starting in 2008, she pioneered the use of botulinum toxin type A in treating children with cerebral palsy, a therapy she has continued to develop and refine. In addition to her clinical practice, Dr. Čolović has served as a professor at the Faculty of Medicine, University of Nis, specializing in physical medicine and rehabilitation, where she trains future healthcare professionals. She has also been a lecturer in pediatric rehabilitation at the College of Health Sciences in Ćupria, Serbia. Dr. Čolović’s career also includes significant involvement in continuing medical education, where she has lectured on topics such as botulinum toxin application and rehabilitation of foot deformities in children.

Awards and Honors🏆

Dr. Hristina Čolović has received numerous awards and honors throughout her distinguished career. She has been recognized for her excellence in both clinical practice and research in the field of physical medicine and rehabilitation. Her contributions to the treatment of children with cerebral palsy using botulinum toxin type A have been particularly noteworthy. In addition to her clinical work, she has earned accolades for her leadership in education and continuous medical training. Dr. Čolović’s research and teaching have been instrumental in advancing pediatric rehabilitation in Serbia and beyond. She has been honored by various medical institutions, including the Serbian Medical Society and the Serbian Medical Chamber. Her role as an invited speaker and lecturer at numerous national and international conferences further highlights her esteemed standing within the medical community. Dr. Čolović’s continued dedication to improving healthcare outcomes, particularly for children with physical disabilities, makes her a respected figure in the field.

Research Focus 🔬:

Dr. Hristina Čolović’s research focuses primarily on pediatric rehabilitation, with a particular emphasis on cerebral palsy and musculoskeletal disorders in children. Her pioneering work on the use of botulinum toxin type A for managing spasticity in children with cerebral palsy has had a significant impact on the field, improving functional outcomes for these children. She is also interested in exploring rehabilitation strategies for other pediatric conditions, such as congenital foot deformities and hip dysplasia. Dr. Čolović’s work involves both clinical applications and functional assessments, aiming to enhance the overall quality of life for children with physical disabilities. Her research contributions include studies on motor activity in premature infants and the effects of rehabilitation interventions on neurological outcomes. Through her research, Dr. Čolović seeks to bridge the gap between innovative treatments and their practical applications in improving the health and mobility of pediatric patients, particularly those with spasticity and developmental disabilities.

📚 Publications

    • A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke
      Authors: Čolović, H., Zlatanović, D., Zivković, V., Jovanović, K., Nikolić, D.
      Citations: 0
      Year: 2024
    • Can pre-treatment dysfunctional voiding and incontinence scoring system score predict treatment outcome in children with dysfunctional voiding – a randomized trial
      Authors: Živković, V.D., Čolović, H., Zlatanović, D., Vlajković, M.
      Citations: 0
      Year: 2023
    • The importance of assessing general motor activity in premature infants for predicting neurological outcomes
      Authors: Zlatanović, D., Čolović, H., Živković, V., Vučić, J., Tošić, T.
      Citations: 1
      Year: 2022
    • Factors associated with poor self-reported function and quality of life in patients with end-stage knee or hip osteoarthritis immediately prior to total joint arthroplasty
      Authors: Kocić, M., Milenković, M., Nikolić, D., Čolović, H., Stojanović, Z.
      Citations: 4
      Year: 2021
    • Endometrial immunocompetent cells in proliferative and secretory phase of normal menstrual cycle
      Authors: Janoševic, D.R., Janoševic, D.R., Trandafilović, M., Dinic, S.P.-T., Dinic, S.P.-T.
      Citations: 12
      Year: 2020
    • Upper limb robotic neurorehabilitation after pediatric stroke
      Authors: Čolović, H., Dimitrijević, L., Đurić, V., Janković, S.
      Citations: 3
      Year: 2020
    • Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
      Authors: Čolović, H., Dimitrijevic, L., Stanković, I., Radović-Janošević, D., Zlatanović, D.
      Citations: 1
      Year: 2020
    • The Role of Early Habilitation in Infants with Congenital Brachial Palsy
      Authors: Živković, V.D., Stanković, I., Dimitrijević, L., Spalević, M., Savić, N.
      Citations: 1
      Year: 2018
    • The effect of physical therapy in the treatment of patients with cervical dystonia with or without concomitant use of botulinum toxin
      Authors: Stanković, I., Čolović, H., Živković, V., Živković, D., Stanković, T.
      Citations: 2
      Year: 2018
    • Chemoinformatic investigation of antibiotic antagonism: The interference of thymus glabrescens essential oil components with the action of streptomycin
      Authors: Ilić, B.S., Miladinović, D.L., Kocić, B.D., Čolović, H., Nikolić, D.M.
      Citations: 3
      Year: 2017

 

Conclusion 

Dr. Hristina Čolović’s profile indicates strong potential for the Robotics Integration Award. Her expertise in physical medicine and rehabilitation, combined with her research into robotic neurorehabilitation, makes her an excellent candidate for recognition. With further development in broader robotics applications and enhanced collaboration with engineers, Dr. Čolović could lead the way in advancing robotic integration into rehabilitation practices, positively impacting patient care across various domains.

 

 

Sandeep Agnihotri | Cognitive Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Sandeep Agnihotri | Cognitive Neuroscience | Best Researcher Award🏆

Research Associate at Guangdong Institute of Intelligence Science and Technology, China
🎓

Raziel Alejandro Arias Sánchez is a highly accomplished researcher with expertise in biotechnology and health sciences, particularly in clinical and experimental pathophysiology. His work focuses on chronic degenerative diseases, including neurodegeneration and diabetes mellitus. At only 27 years old, he has earned academic distinctions and contributed to impactful scientific literature as the primary author of articles and book chapters in reputable journals like Molecules. Raziel has actively participated in conferences, presented research, and contributed to the scientific community through collaborative projects and dissemination activities.

 

Profile 

Education 🎓:

Sandeep Kumar Agnihotri holds a Ph.D. in Cellular and Molecular Biology from Jawaharlal Nehru University (JNU), New Delhi, India, awarded in 2013. His doctoral research focused on the regulation of cadmium-mediated stress responses in mammalian systems. Prior to this, he earned an M.Sc. in Biotechnology from the University of Allahabad in 2006 and a B.Sc. in Life Sciences from Bundelkhand University, Jhansi, in 2000. He has consistently demonstrated academic excellence, securing full scholarships and top honors throughout his academic journey.

 

Work Experience 💼:

With over 15 years of extensive experience, Sandeep is currently a Research Associate at the Guangdong Institute of Intelligence Science and Technology (GDIIST) in China. He collaborates with Suiren Medical Technology to develop diagnostic tools for neurological disorders using EEG, fNIR, and AI data technology. Previously, he worked as a Senior Research Officer at Suiren Medical Technology and as a Postdoctoral Researcher at the Institute of Neuroscience (CEBSIT), Chinese Academy of Sciences, Shanghai. His work includes investigating cancer-associated fibroblasts in retinoblastoma and exploring the metabolic effects of neural stem cells.

🧬 Skills

Sandeep possesses a diverse skill set, including advanced cell biology techniques (3D culture, stem cell isolation, microscopy), molecular biology (CRISPR/Cas9 gene editing, RNAseq analysis), biochemical techniques (enzyme assays, proteomics), and neurobiological tools (stereotaxic injections, neuronal structure analysis). He is proficient in software like MATLAB, Python, R, ImageJ, FlowJo, and RNAseq tools for data analysis. He is also skilled in conducting behavioral studies on mice and applying AI-driven methods for Alzheimer’s diagnosis.

Awards and Honors🏆

Sandeep has received numerous accolades, including scholarships for his Ph.D. and M.Sc. programs, and the prestigious Meritorious Students Award from the University Grants Commission (UGC) in India. His Ph.D. at JNU, ranked among the top universities globally, further underscores his academic prowess.

📚 Teaching Experience

As part of his commitment to knowledge sharing, Sandeep has mentored several researchers and students throughout his career. His expertise in cellular biology, proteomics, and neurobiology has been shared via workshops and practical training sessions, including those on mass spectrometry and advanced proteomics at JNU.

 

📜 Memberships and Conferences

Sandeep actively participates in international conferences, where he has delivered presentations on topics ranging from neurogenesis to mitochondrial dynamics in cadmium toxicity. He has also been associated with collaborative projects, workshops, and training programs in proteomics and molecular biology.

 

Research Focus 🔬:

Sandeep’s research primarily revolves around neurological disorders, with a focus on understanding metabolic pathways in neurogenesis and the impact of neural stem cells on diseases like Parkinson’s and Alzheimer’s. His work also extends to cancer biology, where he has studied tumorigenesis mechanisms in retinoblastoma. He integrates AI tools for diagnosis and cognitive analysis, blending neuroscience with cutting-edge technology.

Conclusion 

Sandeep Kumar Agnihotri is a strong contender for the Best Researcher Award due to his diverse and impactful contributions to neuroscience, oncology, and environmental toxicology. His interdisciplinary approach, innovative research, and commitment to solving real-world problems make him a deserving candidate. With focused efforts on global collaborations, impactful publications, and translational research, he could further solidify his position as a leading figure in the scientific community.

 

📚 Publications

  • “Investigating the Effects of Transcranial Alternating Current Stimulation on Cortical Oscillations and Network Dynamics”
    • Year: 2024
    • Journal: Brain Sciences
  • “Loss of PTEN-Induced Kinase 1 Regulates Oncogenic Ras-Driven Tumor Growth By Inhibiting Mitochondrial Fission”
    • Year: 2022
    • Journal: Frontiers in Oncology
  • “PINK1 deficiency is associated with increased deficits of adult hippocampal neurogenesis and lowers the threshold for stress-induced depression in mice”
    • Year: 2019
    • Journal: Behavioural Brain Research
  • “Mechanistic Effect of Heavy Metals in Neurological Disorder and Brain Cancer”
    • Year: 2019
    • Journal: Networking of Mutagens in Environmental Toxicology (Book Chapter)
  • “Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death”
    • Year: 2018
    • Journal: Scientific Reports
  • “Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus”
    • Year: 2017
    • Journal: Not specified
  • “Cadmium Toxicity Showing Organ Specific Signature of Responsiveness”
    • Year: 2017
    • Journal: Perspectives in Environmental Toxicology (Book Chapter)
  • “Brain most susceptible to cadmium induced oxidative stress in mice”
    • Year: 2015
    • Journal: Not specified

 

 

 

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr NISHI PATEL | Neuroscience | Best Researcher Award   🏆

Research Scholar at Bhagwan Mahavir University, Surat , India🎓

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease 🧠. With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinson’s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional Profile 

  • Google Scholar 

Education 🎓

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience 🏢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors 🏆

While specific awards are not mentioned, Dr. Patel’s numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus 🔍

Dr. Patel’s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinson’s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications : 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum – An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinson’s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179

Dr Sumana Chakravarty | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Sumana Chakravarty |  Neuroscience | Best Researcher Award 

Senior Principal Scientist at CSIR-Indian Institute of Chemical Technology, India

📚 👩‍🔬 Dr. Sumana Chakravarty is a Senior Principal Scientist at CSIR Indian Institute of Chemical Technology, Hyderabad. With over two decades of experience in chemical and biomedical research, she has made significant contributions to the understanding of psychiatric and neurological disorders, focusing on sexual dimorphism in disease mechanisms. 🧬 Her work is pivotal in advancing drug discovery for gender-specific treatments.

Professional Profile:

Education

🎓 Ph.D. in Zoology (Male Reproductive Physiology) – Banaras Hindu University, 1997
🎓 M.Sc. in Zoology/Reproductive Physiology – Banaras Hindu University, 1988
🎓 B.Sc. (Honors) in Botany, Zoology, Chemistry, and English – Banaras Hindu University, 1986

Professional Experience

🔬 Senior Principal Scientist – Indian Institute of Chemical Technology, Hyderabad (2021-Present)
📚 Principal Scientist – Indian Institute of Chemical Technology, Hyderabad (2016-2021)
👩‍🏫 Associate Professor – AcSIR (2016-Present)
🔬 Scientist in Quick Recruitment Scheme – IICT, Hyderabad (2013-2016)
📚 Assistant Professor – AcSIR (2013-2016)
👩‍🏫 Guest Faculty – NIPER-Hyderabad (2012-2018)
🔬 Ramalingaswami Re-entry Fellow – IICT, Hyderabad (2009-2013)
👩‍🏫 Instructor (Junior Faculty) – UTSW Medical Center, Dallas, USA (2005-2008)
🔬 Postdoctoral Fellowships – UTSW Medical Center, Dallas, USA (1999-2005)
🔬 Research Associate – ICGEB, New Delhi (1997-1998)
📚 Research Scholar – Banaras Hindu University (1989-1997)

Awards and Honors

🏆 2024 – WSN Award in Science and Research
📝 2024 – Guest Editor, Journal of Cellular and Molecular Neurobiology
📚 2024 – Editorial Board Member, Neuromolecular Medicine
🌟 2023 – Member, American Psychological Association
📚 2022 – Associate Editor, Frontiers in Neuroscience
🌐 2022 – Ambassador, ALBA Network
🌟 2022 – Inspiring Women Leader, Merck India
📖 2021 – Featured by The Life of Science
🏅 2021 – SERB-POWER Fellowship Award
🌟 2020 – Featured in Million in STEM
🏆 2008 – Ramalingaswami Re-entry Fellowship
🌟 2005 – Instructor, Dept. of Psychiatry, UTSW Medical Center
🏅 2003 – Departmental Representative, UTSW Medical Center
🏅 2000 – NIH Postdoctoral Fellowship, UTSW Medical Center
🎓 1997 – Research Associate, Talwar Research Foundation
🎓 1991 – UGC Fellowship, BHU
🎓 1989 – BHU Research Fellowship

Research Focus

🔬 Biomedical Research – Focus on sexual dimorphism in psychiatric and neurological disorders
🧬 CNS Disorders – Stress-induced behavioral disorders, cerebral ischemia models
🐭 Animal Models – Mouse and zebrafish models for neuro-disease research
🌿 Natural Products – Identifying neuroprotective compounds
💡 Drug Discovery – Developing new targets and biomarkers for CNS disorders

Publications: 

  • Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions
    • Authors: V Krishnan, MH Han, DL Graham, O Berton, W Renthal, SJ Russo, …
    • Journal: Cell
    • Year: 2007
    • Volume and Issue: 131 (2)
    • Pages: 391-404
    • Cited by: 2451
    • 🧠
  • Mania-like behavior induced by disruption of CLOCK
    • Authors: K Roybal, D Theobold, A Graham, JA DiNieri, SJ Russo, V Krishnan, …
    • Journal: Proceedings of the National Academy of Sciences
    • Year: 2007
    • Volume and Issue: 104 (15)
    • Pages: 6406-6411
    • Cited by: 921
    • ⏰
  • Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins
    • Authors: W Renthal, A Kumar, G Xiao, M Wilkinson, HE Covington, I Maze, …
    • Journal: Neuron
    • Year: 2009
    • Cited by: 416
    • 🧬
  • CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits
    • Authors: DL Wallace, MH Han, DL Graham, TA Green, V Vialou, SD Iniguez, …
    • Journal: Nature Neuroscience
    • Year: 2009
    • Cited by: 366
    • 🧪
  • Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior
    • Authors: S Mukherjee, L Coque, JL Cao, J Kumar, S Chakravarty, A Asaithamby, …
    • Journal: Biological Psychiatry
    • Year: 2010
    • Cited by: 244
    • ⏰
  • Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
    • Authors: PK Bagul, H Middela, S Matapally, R Padiya, T Bastia, K Madhusudana, …
    • Journal: Pharmacological Research
    • Year: 2012
    • Cited by: 237
    • 🍇
  • The influence of ΔFosB in the nucleus accumbens on natural reward-related behavior
    • Authors: DL Wallace, V Vialou, L Rios, TL Carle-Florence, S Chakravarty, A Kumar, …
    • Journal: Journal of Neuroscience
    • Year: 20087
    • Cited by: 225
    • 🎯
  • Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: altered brain proteome profile implicates mitochondrial dysfunction
    • Authors: S Chakravarty, BR Reddy, SR Sudhakar, S Saxena, T Das, V Meghah, …
    • Journal: PloS One
    • Year: 2013
    • Cited by: 189
    • 🐟
  • Role of nuclear factor κB in ovarian hormone-mediated stress hypersensitivity in female mice
    • Authors: Q LaPlant, S Chakravarty, V Vialou, S Mukherjee, JW Koo, G Kalahasti, …
    • Journal: Biological Psychiatry
    • Year: 2009
    • Cited by: 152
    • 🌼
  • Androgens augment proximal tubule transport
    • Authors: A Quan, S Chakravarty, JK Chen, JC Chen, S Loleh, N Saini, RC Harris, …
    • Journal: American Journal of Physiology-Renal Physiology
    • Year: 2004
    • Cited by: 152
    • 🚰